
Review of "Late
Term" Fetal Deaths, Utah, 1996 & 1997

The Perinatal Mortality Review Program (PMRP)(see "description of program"), of the Utah Department of Health
(UDOH)
reviewed all late term fetal deaths (35 weeks or greater) that did not have a lethal
anomaly and occurred in Utah during the years 1996 and 1997. A total of 453 fetal deaths
occurred during this period, 132 of these met the PMRP criteria for review. This
represents approximately 29% of all fetal deaths during these years.
The definition of fetal death by the UDOH, Bureau of Vital Records
is "a product of human conception: (a) of 20 weeks gestation or more,
calculated from the date the last normal menstrual period began to the date of delivery;
and (b) that was not born alive."1 The average fetal death ratio (fetal deaths per 1000 live births) in Utah
during 1996 & 1997 was 5.3/1000. The Healthy People 2000 Objectives include the
recommendation to reduce the fetal death ratio to no more than 5 per 1000 live births.2 The PMRP undertook the
review of fetal deaths in order to identify public health strategies which may reduce the
fetal death ratio.
The ages of Mothers experiencing fetal deaths reviewed
ranged from 16 to 43 years with a mean of 28 years. Age specific fetal death ratios were
highest among women 40-49 years of age (4.8/1000),(graph 1). Approximately 82% of Mothers
experiencing fetal deaths reviewed began PNC during the first trimester of pregnancy, this
is similar to the entire birth population in Utah during this time period. A very small
percentage of Mothers included in the study group received late (3rd trimester)
or no prenatal care (3.2%).
Graph
1

Fetal death ratios by Mothers county of
residence indicate that women living in rural Utah counties had a higher ratio of fetal
deaths (1.9/1000) compared to those living in urban counties (1.4/1000). This increased
risk may be due to lack of access to obstetricians in rural Utah. More than half of rural
Utah counties (16 out of 29) are without any obstetrician.3
Fetal death ratios were found to be higher among women with 3 or
more previous livebirths (graph 2). Additional statistical analysis is needed to determine
if this variable is confounded by maternal age.
Graph 2

Approximately 27% of fetal deaths reviewed occurred in Mothers
whose body mass index (BMI) was rated as "high" or "obese"(Graph 3).
This finding requires further research in light of the recently published findings of
higher maternal weight before pregnancy increasing the risk of late fetal deaths.4
Graph 3

The Perinatal Mortality Review Committee (PMRC) deliberated
following the review of each fetal death. Issues that may have contributed to the death
were identified. The most frequently identified pregnancy related socio-demographic issue
was a delay on the part of the Mother to seek care immediately when fetal movement was
noted to be decreased or absent. This issue was identified in 52 of the 132 cases (39%).
Other socio-demographic issues identified include: poverty (14.4%), being uninsured
(8.3%), unintended pregnancy (8.3%) and being unmarried (12.3%), all of which are common
risk factors for poor perinatal outcomes.
Pregnancy complications that may have contributed to the fetal
deaths reviewed were also identified by the PMRC. Placental complications were identified
in 36% of the cases reviewed, the most common of which were "abnormal placenta or
cord"(n=23) and placental abruption (n=20). Other complications included:
intra-uterine growth retardation (4.6%), gestational diabetes (5.3%), insufficient weight
gain during pregnancy (6.9%), pregnancy-induced hypertension (6.1%) and oligohydramnios
(4.6%). Again, all are well recognized risk factors for poor perinatal outcomes.
The PMRC identified medical care provider issues, that may have
contributed to the fetal death, in many of the cases reviewed. These issues included
delay/lack of diagnosis or treatment (9.2%), mismanagement (8.1%) and misdiagnosis (3.8%).
In addition, only 20.5% of women who experienced a fetal death were referred to a
specialist for care during their pregnancy. A list of PMRC recommendations was developed
during the review process (Table 1).
During the development of the process for reviewing these fetal deaths, it became
apparent that lack of information was a barrier. Many death certificates list
"unknown" as the cause of death,
(Table 3) therefore, the committee
decided to illustrate this critical issue by reporting on the lack of post-mortem
assessment that occurs. Components of a complete fetal death workup include the following
items: maternal history, family history, x-rays, photos, cultures, karyotype, placental
exam, maternal blood work (including torch, APLA/LAC, KB, indirect coombs) and tox screen.5
Table 2 illustrates the number of
cases in which post-mortem assessment was accomplished.
Review of fetal deaths is an ongoing responsibility of the
PMRP.
Development of public health interventions using PMRC recommendations is currently
underway. It is hoped that these interventions will help to prevent these perinatal
tragedies and promote healthy outcomes for pregnant women in Utah.
Table 1
Committee Recommendations |
Frequency |
| Fetal Movement Count Issues: |
27 |
| Patient education regarding fetal movement
counts and prompt seeking of care with decreased fetal movement |
27 |
| Antepartum Assessment Issues: |
20 |
| Follow up for Fifths disease needed
with 3rd trimester ultrasound |
1 |
| Provider recognition of mild hypertension
and potential association with placental insufficiency |
1 |
| With probable evidence of acute fetal
vascular catastrophe, antepartum testing should be done |
1 |
| Work-up for PIH should have been more
extensive |
1 |
| Need adequate prenatal screening to
determine gestational diabetes |
2 |
| Provider education regarding relationship
between fetal tachycardia and oligohydramnios |
1 |
| Antepartum surveillance should begin at 32
weeks in healthy pregnancy women with a history of previous stillbirth |
1 |
| Adequate antepartum assessment for
discordant twins |
1 |
| Assess amniotic fluid volume with ultra
sound exam |
1 |
| Assess amniotic fluid volume with non
stress test |
2 |
| Continuous fetal monitoring during labor
when tracing is not reassuring |
1 |
| Assess blood glucose levels in women with
gestational diabetes, particularly when receiving weekly steroid injections |
1 |
| Should have had karyotype to confirm
diagnosis of Trisomy 21 |
1 |
| Ultrasound assessment of presumed SGA
infant is necessary |
1 |
| Unrecognized IUGR |
1 |
| Diagnosis should be followed with
appropriate work-up |
1 |
| No documented record of NST |
1 |
| Follow up on foul smelling amniotic fluid |
1 |
| Documentation/Communication issues: |
16 |
| Medical records needed to note reason for
admission, e.g. decreased fetal movement |
1 |
| Medical records should have indicated
whether fetal heart tracing was reassuring or not |
1 |
| Provider needs to dictate record if
handwriting is illegible |
1 |
| With positive urine culture, need
documentation of treatment |
1 |
| Inadequate documentation of any attempt to
diagnose |
1 |
| Limited ability to review death as
hospital lost medical records |
2 |
| Cannot determine cause of death due to
lack of information |
1 |
| FAX prenatal care records to tertiary care
hospital when transporting patient |
1 |
| Document how long since fetal movement
detected |
1 |
| Adequate documentation of procedures in
medical records |
1 |
| Better communication between referring
provider and the referral hospital |
1 |
| Better communication between providers
when patient is receiving care in two locations |
1 |
| Better documentation by provider of
history immediately prior to fetal death |
1 |
| Better documentation of history by
provider who treated Mom |
1 |
| Records need to include results of lab
work |
1 |
| Post-mortem assessment issues: |
10 |
| Follow-up with placental cultures for
maternal infection |
1 |
| Autopsy authorized, but no report |
1 |
| Need to document fetal weight |
3 |
| Need for autopsy |
2 |
| Parents refused autopsy |
2 |
| MRI autopsy only |
1 |
| Consult/referral issues: |
7 |
| Referral for nutritional counseling |
1 |
| High risk patients should not be managed
by midwives |
1 |
| General practitioner needed to seek
consultation with obstetrician |
1 |
| Pregnant women with insulin dependent
diabetes should not be managed by family practice physician, should be referred to
obstetrician |
1 |
| Patients with high risk OB history need to
be followed by MD |
1 |
| Referral to follow up for further
assessment |
1 |
| Consult or refer to obstetrician |
1 |
| Prenatal Care issues: |
5 |
| Prenatal care providers need to follow-up
with no show patients, especially those who are high risk |
1 |
| Patient should have sought prenatal care |
1 |
| Better follow-up with non compliant
patients |
1 |
| Need to coordinate with medicaid for
transportation for patients who have a need |
1 |
| Follow-up on missed prenatal care visits
(no visits for two months) |
1 |
| Medical care issues: |
5 |
| Assume knee chest position for transport
with prolapsed cord |
1 |
| Close follow-up of pre existing seizure
disorder |
1 |
| Follow-up on positive RPR |
1 |
| Follow-up with appropriate cultures after
diagnosis of chorioamnionitis |
1 |
| Educate provider on need for insulin in
patients with elevated fasting blood/urine glucose levels |
1 |
| Substance use screening/referral
issues: |
4 |
| Need tox screen in patients with history
of substance abuse |
1 |
| Need tox screen in patients who present
with placental abruption |
2 |
| Smoking cessation referral |
1 |
| Domestic Violence issues: |
2 |
| Screen for domestic violence when patient
presents with bruising, and/or abruption |
2 |
REFERENCES:
1) Division of Community and Family Health Services. Report
on Maternal and Infant Health in Utah. Salt Lake City, UT: Utah Department
of Health, 1997; pg. 4.2.
2) Healthy People 2000 National Health Promotion and disease
Prevention Objectives. DHEW publication no. PHS91-50212. Hyattsville, MD: US Department of
Health and Human Services, 1991.
3)Division of Community and Family Health Services. Report on
Maternal and Infant Health in Utah. Salt Lake City, UT: Utah Department of Health,
1997.
4) Cnattingius, S., Bergstrom, R., Lipworth, L. and Kramer, M.
Prepregnancy Weight and the Risk of Adverse Pregnancy Outcomes. NEJM 1998;338,3:147-152.
5) Incerpi, M., Miller, D., Samadi, R., Settlage, R. &
Goodwin, T. Stillbirth evaluation: What tests are needed? Am J Obstst Gynecol
1998;178,6:1121-1125.
For more information e-mail us or call (801)538-9970.